DalsnaFinance › Analyst accuracy › Citizens JMP › MIRM target
Citizens raises Mirum Pharmaceuticals stock price target on HDV data
raised its price target on Mirum Pharmaceuticals shares to $144 from $137 while maintaining a Market Outperform rating
A fact about what Citizens JMP published, as reported by Investing.com, not a recommendation from Dalsna Finance; Citizens JMP is not affiliated with this site.
Full methodology: how targets are collected, scored, ranked and corrected, what each field means, and how to cite the data.